Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sight Sciences, Inc. | Chief Financial Officer | Common Stock | 393K | $2.39M | $6.08 | Oct 1, 2024 | Direct |
Inogen Inc | EVP, Finance, & CFO | Common Stock | 33.9K | $194K | $5.72 | Dec 1, 2021 | Direct |
Inogen Inc | EVP, Finance, & CFO | Restricted Stock Unit | 4.92K | $28.1K | $5.72 | Dec 1, 2021 | Direct |
Pear Therapeutics, Inc. | Director | Class A Common Stock | 71.4K | Feb 15, 2023 | Direct | ||
GELESIS HOLDINGS, INC. | Director | Common Stock | 51.1K | May 6, 2022 | Direct | ||
Inogen Inc | EVP, Finance, & CFO | Stock Option (Right to Buy) | 0 | Dec 15, 2020 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGHT | Sight Sciences, Inc. | Oct 1, 2024 | 1 | -$61.6K | 4 | Oct 3, 2024 | Chief Financial Officer |
SGHT | Sight Sciences, Inc. | Jul 2, 2024 | 1 | -$65.2K | 4 | Jul 3, 2024 | Chief Financial Officer |
SGHT | Sight Sciences, Inc. | May 17, 2024 | 1 | -$70.9K | 4 | May 20, 2024 | Chief Financial Officer |
SGHT | Sight Sciences, Inc. | Apr 3, 2024 | 1 | -$51.4K | 4 | Apr 4, 2024 | Chief Financial Officer |
SGHT | Sight Sciences, Inc. | Feb 14, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Financial Officer |
SGHT | Sight Sciences, Inc. | May 9, 2023 | 2 | $0 | 4 | May 11, 2023 | Chief Financial Officer and Treasurer |
SGHT | Sight Sciences, Inc. | Apr 3, 2023 | 0 | $0 | 3 | Apr 5, 2023 | Exhibit list: Exhibit 24 - Power of Attorney Chief Financial Officer and Treasurer |
PEARQ | Pear Therapeutics, Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director |
PEARQ | Pear Therapeutics, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
GLSH | GELESIS HOLDINGS, INC. | May 6, 2022 | 1 | $0 | 4 | May 9, 2022 | Director |
GLSH | GELESIS HOLDINGS, INC. | Jan 13, 2022 | 0 | $0 | 3 | Jan 24, 2022 | Director |
PEARQ | Pear Therapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 1 | $0 | 4 | Dec 7, 2021 | Director |
PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 0 | $0 | 3 | Dec 7, 2021 | Director |
INGN | Inogen Inc | Dec 1, 2021 | 3 | -$14.5K | 4 | Dec 3, 2021 | EVP, Finance, & CFO |
INGN | Inogen Inc | Sep 1, 2021 | 5 | -$37.3K | 4 | Sep 3, 2021 | EVP, Finance, & CFO |
INGN | Inogen Inc | Jul 30, 2021 | 6 | -$400K | 4 | Aug 3, 2021 | EVP, Finance, & CFO |
INGN | Inogen Inc | Jul 27, 2021 | 3 | -$351K | 4 | Jul 29, 2021 | EVP, Finance, & CFO |
INGN | Inogen Inc | Jun 1, 2021 | 5 | -$37K | 4/A | Sep 3, 2021 | EVP, Finance, & CFO |
INGN | Inogen Inc | Dec 15, 2020 | 5 | -$205K | 4/A | Dec 3, 2021 | EVP, Finance, & CFO |